14 November 2020 · This edition of NICE Bites reflects current NICE guidance (as at November 2020) but the NICE guideline on assessing fracture risk is being updated. Please…
18 September 2020 · Drugs used exclusively for postmenopausal osteoporosis have not been included. Bisphosphonates have very poor oral bioavailability in fasting adults, which is decreased even further in…
9 July 2020 · In the main, bisphosphonates are not metabolised and are excreted unchanged in urine. Oral bisphosphonates are licensed for the primary and secondary prevention of osteoporotic…
25 February 2020 · This updated Medicines Q&A evaluates the published evidence examining the gastric safety of bisphosphonates for the treatment of osteoporosis. Alendronate should be the first choice…